PUBLICATION ALERT: Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis

Check out the latest study by Portnoy et al. (2023) on the economic costs of tuberculosis treatment in low- and middle-income countries. The study delves into the often-overlooked financial burdens faced by patients, even in the presence of ostensibly free treatment. By synthesizing data from 22 national surveys conducted between 2015 and 2022, the authors […]

PUBLICATION ALERT: The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study

Discover the potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries through a recently published modeling study in PLOS Medicine. In this study, Assistant Professor Allison Portnoy uncovers significant potential for these vaccines to drive substantial GDP gains, fostering economic development in LMICs. Read more about this exciting work […]

PUBLICATION ALERT: The Potential Impact of Novel Tuberculosis Vaccines on Health Equity and Financial Protection in Low-Income and Middle-Income Countries

Introducing a recently published paper in BMJ Global Health  by Assistant Professor Allison Portnoy titled “The Potential Impact of Novel Tuberculosis Vaccines on Health Equity and Financial Protection in Low-Income and Middle-Income Countries.” The study reveals that these vaccines can significantly reduce financial vulnerability and improve health outcomes, particularly for lower-income groups. Read more about […]